Matthew Herper

Moncef Slaoui, who ran the Operation Warp Speed Covid vaccine effort, is becoming chair of Curevo, a company developing a new shingles vaccine

The longtime director of the National Human Genome Research Institute is stepping down, as the larger NIH braces for more changes.

The genetics company's bankruptcy is bad for co-founder Anne Wojcicki and shareholders. But customers whose data may not be protected are worst off.

WASHINGTON — Around 3,500 employees are on the chopping block at the Food and Drug Administration, but they don’t yet know who they are. The Health

Deputy directors at the FDA center that oversees the regulation of cancer drugs plan to leave, adding to a flood of top talent in recent months.

Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.

Why the ouster of Peter Marks, a senior FDA official, is a huge deal, whether you liked him or not.

A former top FDA official said it’s only a matter of time before the chaos at the agency starts to impact drug reviews.

Trump's health secretary told FDA workers that tackling childhood chronic diseases should be the agency's chief priority.

Dear readers: You come to STAT for tough, smart journalism that helps you think about big topics like how AI will change medicine and the upheaval enveloping U.S. science.